Edward M. Md Kaye Stoke Therapeutics, Inc. (STOK) insider trading activity

Edward M. Md Kaye is of Stoke Therapeutics, Inc.. Currently has a direct ownership of 62,554 shares of STOK, which is worth approximately $1.66 Million. The most recent transaction as insider was on Mar 27, 2023, when has been sold 20,000 shares (Common Stock) at a price of $0.6 per share, resulting in proceeds of $12,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.6K

31.7% 3M change

8.91% 12M change

Total Value Held $1.66 Million

Edward M. MD Kaye Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 27 2023	BUY Exercise of conversion of derivative security	$12,000 $0.6 p/Share	20,000 Added 30.77%	45,000 Common Stock
May 25 2022	BUY Exercise of conversion of derivative security	$9,000 $0.6 p/Share	15,000 Added 37.5%	25,000 Common Stock
Dec 30 2020	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 50.0%	10,000 Common Stock
Dec 18 2020	SELL Open market or private sale	$311,640 $60.0 p/Share	5,194 Reduced 100.0%	0 Common Stock
Dec 17 2020	SELL Open market or private sale	$1,188,360 $60.0 p/Share	19,806 Reduced 79.22%	5,194 Common Stock
Nov 27 2020	SELL Open market or private sale	$607,600 $50.0 p/Share	12,152 Reduced 32.71%	25,000 Common Stock
Nov 25 2020	SELL Open market or private sale	$642,400 $50.0 p/Share	12,848 Reduced 25.7%	37,152 Common Stock

Also insider at

CYTK

CYTOKINETICS INC Healthcare

Director

RNA

Avidity Biosciences, Inc. Healthcare

Director

EMM

Edward M. Md Kaye

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Value

Insider Trading

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Stoke Therapeutics, Inc.

Track Activities on STOK

Account